A search for a new anticonvulsant and anxiolytic benzodiazepine devoid of side effects and tolerance liability.
Costa
E
E
Department of Neurology, Washington University, St. Louis, MO, USA.
Auta
J
J
Caruncho
H
H
Guidotti
A
A
Impagnatiello
F
F
Pesold
C
C
Thompson
D M
DM
D000818:Animals; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D000927:Anticonvulsants / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D001569:Benzodiazepines; D004361:Drug Tolerance; D018682:GABA Agents / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D011963:Receptors, GABA-A / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D019966:Substance-Related Disorders
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D018682:GABA Agents; D011963:Receptors, GABA-A; D001569:Benzodiazepines